Reports & Commentary - Health

Almirall gets validation for 2050 net zero goal

The Spanish pharmaceutical company has also committed to reducing absolute Scope 1 and 2 emissions by 50% and Scope 3 emissions by 28% by 2030.

150 150 Trove Research

AstraZeneca to invest USD 400m in afforestation project

AstraZeneca recently announced plans to invest USD 400 million in the afforestation initiative AZ Forest, with projects in Brazil, India, Vietnam, Ghana and Rwanda.

150 150 Trove Research

Qiagen receives approval for its net zero target

The global pharmaceutical company has pledged to hit net zero greenhouse gas (GHG) emissions by 2050, its absolute reductions measured from a 2020 base year.

150 150 Trove Research

Medtronic commits to net zero by 2045

The American medical device manufacturer has set an interim goal of being carbon neutral by 2030 as part of its commitment to the SBTi.

150 150 Trove Research

Elekta’s climate targets validated by SBTi

The SBTi has validated various 2030 targets on Scopes 1, 2 and 3 of the Swedish medical equipment manufacturer.

150 150 Trove Research

Astellas commits to achieve net zero by 2050

The Japanese pharmaceutical company Astellas Pharma announced its commitment to reducing GHG emissions in its scopes 1, 2, and 3 by 90% by 2050.

150 150 Trove Research

Viatris’s near-term targets approved by SBTi

The US-based pharmaceutical company, born of the merger of Mylan and UpJohn, has commited to reduce scope 1 and 2 GHG emissions by 42% by 2030.

150 150 Trove Research

Pfizer accelerates climate action to achieve net-zero by 2040

Pfizer announced a commitment to achieve the voluntary Net-Zero Standard by 2040, ten years earlier than the timeline described in the standard. Pfizer aims to decrease its GHG emissions by…

150 150 Trove Research

61 US organisations join ‘Health Sector Climate Pledge’

Pfizer, AstraZeneca, Kaiser Permanente, Philips, amongst group to join Biden Administration’s pledge to reduce GHG emissions by 50% by 2030.

150 150 Trove Research

NHS launches ‘green plan’ to decarbonise estates

The plan is part of the NHS's ‘Delivering a Greener NHS’ programme, which aims to achieve net-zero by 2040.

150 150 Trove Research

Amgen issues inaugural $750m green bond

Amgen announced the issuance of its inaugural $750 million green bond, with a 3.00% semi-annual coupon and maturing in 2029.

150 150 Trove Research

Sanofi pulls carbon neutral goal forward to 203

Among Pharmaceutical group Sanofi's CSR strategy updates is also a new 2050 net zero objective.

150 150 Trove Research

Bupa targets net-zero emissions by 2040

International healthcare company Bupa has joined the UN's Race to Zero programme and has pledged to reach net-zero emissions by 2040.

150 150 Trove Research

Charles River Laboratories signs 250 MWh solar project

Pharmaceutical research tools provider Charles River Laboratories International announced a long-term solar energy contract to address the entirety of its North American electric power requirements with renewable energy by 2023.

150 150 Trove Research

JBS, Pfizer, others join Business Ambition for 1.5°C

New Business Ambition for 1.5°C campaign signees include: Kenya Electricity Generating Company (electricity-Kenya), Yum China Holdings (restaurants-China), JBS (meat processing-Brazil), Vistra (electricity-US), Boehringer Ingelheim (pharameuticals-US), Pfizer (pharameuticals-US), Corteva Agriscience (chemicals-US), …

150 150 Trove Research
Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

By customising your privacy preference, you agree to continue to use this site as per your selected privacy preferences

We use cookies to give you the best online experience. By clicking I Agree and/or continuing to use our site, we assume you are happy to proceed with our default privacy settings, or, if applicable, the settings you have selected via Privacy Preferences.